ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 321 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $160,000 | +122.2% | 441 | 0.0% | 0.00% | +100.0% |
| Q2 2015 | $72,000 | -24.2% | 441 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $95,000 | -60.3% | 441 | -53.7% | 0.00% | -60.0% |
| Q4 2014 | $239,000 | +1393.8% | 952 | +1730.8% | 0.01% | – |
| Q3 2014 | $16,000 | -42.9% | 52 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $28,000 | +27.3% | 52 | 0.0% | 0.00% | – |
| Q1 2014 | $22,000 | -69.9% | 52 | -95.8% | 0.00% | -100.0% |
| Q4 2013 | $73,000 | -37.6% | 1,250 | -11.3% | 0.00% | -50.0% |
| Q3 2013 | $117,000 | – | 1,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,634,838 | $268,180,000 | 8.50% |
| DOWLING & YAHNKE LLC | 676,379 | $27,339,000 | 3.72% |
| WILLIAM HARRIS INVESTORS INC | 317,301 | $12,826,000 | 3.63% |
| Opus Point Partners Management, LLC | 101,401 | $4,099,000 | 2.26% |
| SOUND ENERGY PARTNERS, INC. | 25,000 | $1,011,000 | 2.04% |
| Sonora Investment Management, LLC | 127,104 | $6,622,000 | 2.00% |
| PINNACLE ASSOCIATES LTD | 1,778,325 | $71,880,000 | 1.59% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 17,000 | $687,000 | 1.36% |
| Apex Capital Management | 1,019,618 | $41,213,000 | 0.93% |
| PERKINS CAPITAL MANAGEMENT INC | 20,350 | $823,000 | 0.92% |